Precigen, Inc. (PGEN) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 11 Buy, 4 Hold, 1 Sell.
The consensus price target is $6.00, representing an upside of 51.5% from the current price $3.96.
Analysts estimate Earnings Per Share (EPS) of $-0.45 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.47 vs est $-0.45 (missed -4.4%). 2025: actual $-1.41 vs est $-1.11 (missed -27%). Analyst accuracy: 87%.
PGEN Stock — 12-Month Price Forecast
$6.00
▲ +51.52% Upside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Precigen, Inc., the price target is $6.00.
The average price target represents a +51.52% change from the last price of $3.96.
PGEN Analyst Ratings
Buy
Based on 16 analysts giving stock ratings to Precigen, Inc. in the past 3 months
EPS Estimates — PGEN
87%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.47
vs Est –$0.45
▼ 4.3% off
2025
Actual –$1.41
vs Est –$1.11
▼ 21.3% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — PGEN
56%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $0.004B
vs Est $0.006B
▼ 47.8% off
2025
Actual $0.010B
vs Est $0.014B
▼ 39.7% off
Revenue Trend
Strong revenue growth over the period shown. Analysts forecast revenue contraction ahead.
